13G Filing: Armistice Capital and Vanda Pharmaceuticals Inc. (VNDA)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
Posts Tagged ‘Vanda Pharmaceuticals Inc. (VNDA)’
Vanda Pharmaceuticals Inc. (VNDA) Stock: Deerfield Management Cashes In 2.56 Million Shares
According to a freshly-amended 13G filing with the Securities and Exchange Commission, James E. Flynn‘s Deerfield Management has sold around......(read more)
Here’s Why Traders Are Buzzing about These Five Stocks
Fading chances of a rate hike soothed the market sentiment on Wednesday. Some important stocks which are making headlines today, include Vornado Realty......(read more)
Smart Money Is Seeing Upside For These Three Companies
Three companies have recently been the subject of bullish moves by hedge funds. Let us take a look at what makes these companies seem undervalued to hedgies......(read more)
These Five Biotech Stocks Ranked Among This UK-based Fund’s Favorites
Cheyne Capital is one of the few non-U.S firms that we track in our database. Managed by its founders, Jonathan Lourie and Stuart Fiertz, Cheyne employs......(read more)
Stonepine Capital Management Reveals 5.5% Stake in Vanda Pharmaceuticals Inc. (VNDA)
In a new filing with the Securities and Exchange Commission, Stonepine Capital Management disclosed a passive stake in Vanda Pharmaceuticals Inc. (NASDAQ......(read more)
Vanda Pharmaceuticals Inc (VNDA): Deerfield Management Increases Exposure Following Positive Announcement
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday. After adding more than 1......(read more)
Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio. One of the companies involved......(read more)
Cubist Pharmaceuticals Inc (CBST), Trius Therapeutics, Inc. (TSRX): This Week in Biotech
With the SPDR S&P Biotech Index up 43% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
Sanofi SA (ADR) (SNY), Vanda Pharmaceuticals Inc. (VNDA), Merck & Co., Inc. (MRK) – Sleep War Z: A Written History of the Insomniac War
It’s estimated that 30% to 40% of adults in the world experience some degree of insomnia every year. Most of these cases aren’t chronic and do not......(read more)
Micron Technology, Inc. (MU) Calls Change Hands At A Clip Ahead of Earnings After The Close
Micron Technology, Inc. (NASDAQ:MU) – Options traders appear to be snapping up out of the money call options on Micron Technology, Inc. (NASDAQ:MU) ......(read more)
Discovery Laboratories, Inc. (DSCO): Are Hedge Funds Right About This Stock?
Is Discovery Laboratories, Inc. (NASDAQ:DSCO) a healthy stock for your portfolio? Investors who are in the know are getting less optimistic. The number......(read more)
Assessing Raptor Pharmaceutical Corp. (RPTP)’s Agreement With HealthCare Royalty Partners
Raptor Pharmaceutical Corp. (NASDAQ:RPTP) signed an agreement with HealthCare Royalty Partners. On the face, this deal looks good for shareholders injecting......(read more)
Bristol Myers Squibb Co (BMY), Momenta Pharmaceuticals, Inc. (MNTA): White Collar Criminals Love Biotech Stocks
It’s understandably very tempting for people with inside information to trade biotech stocks. With the potential for overnight doubles and triples......(read more)
This Metric Says You Are Smart to Buy Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has experienced an increase in enthusiasm from smart money in recent months. In the 21st century investor’s......(read more)
Is Complete Genomics, Inc. (GNOM) Going to Reward These Hedge Funds?
Complete Genomics, Inc. (NASDAQ:GNOM) was in 9 hedge funds’ portfolio at the end of the fourth quarter of 2012. GNOM investors should pay attention......(read more)
Oncothyreon Inc (USA) (ONTY): Are Hedge Funds Right About This Stock?
Oncothyreon Inc (USA) (NASDAQ:ONTY) was in 9 hedge funds’ portfolio at the end of the fourth quarter of 2012. ONTY shareholders have witnessed a......(read more)
Avoid This Biotech Stock: Chelsea Therapeutics International Ltd. (CHTP)
Editor’s note: This article is a stock pitch made by a member on CAPS, The Motley Fool’s free investing community. The pitch is published......(read more)
